Pharma Reviews: Covishield will get EMA approval in a month, says Adar Poonawala at Indian Global Forum 2021

New Delhi: Serum Institute of India is confident of receiving approval from the European Medicines Agency (EMA) for its COVID-19 vaccine Covishield in a month, the company's CEO Adar Poonawalla informed on Wednesday. ... Addressing at India Global Forum 2021, Poonawalla said, "It is not a ...
Read more: Covishield will get EMA approval in a month, says Adar Poonawala at Indian Global Forum 2021

Pharma Reviews: Five drug makers collaborate for clinical trial of Molnupiravir

Sun Pharmaceutical Industries is the world's fourth largest specialty generic pharmaceutical company and India's top pharmaceutical company. Shares ...
Read more: Five drug makers collaborate for clinical trial of Molnupiravir

US FDA News: FDA Approves Component of Treatment Regimen for Most Common Childhood Cancer

The FDA approved a drug as a component of a chemotherapy regimen to treat acute lymphoblastic leukemia and lymphoblastic lymphoma in adult and pediatric patients who are allergic to the E. coli-derived asparaginase products used most commonly for treatment.
Read more: FDA Approves Component of Treatment Regimen for Most Common Childhood Cancer

US FDA News: FDA In Brief: FDA Revokes Emergency Use Authorizations for Certain Respirators and Decontamination Systems as Access to N95s Increases Nationwide

FDA announced it is revoking EUAs of all non-NIOSH-approved disposable respirators, which includes imported disposable respirators such as KN95s, along with revoking EUAs for decontamination and bioburden reduction systems.
Read more: FDA In Brief: FDA Revokes Emergency Use Authorizations for Certain Respirators and Decontamination Systems as Access to N95s Increases Nationwide

US FDA News: Update: FDA No Longer Authorizes Use of Non-NIOSH-Approved or Decontaminated Disposable Respirators - Letter to Health Care Personnel and Facilities

The FDA revoked the emergency use authorizations for non-NIOSH-approved disposable respirators and the EUAs for decontamination and bioburden reduction systems.
Read more: Update: FDA No Longer Authorizes Use of Non-NIOSH-Approved or Decontaminated Disposable Respirators - Letter to Health Care Personnel and Facilities

US FDA News: Certain Philips Respironics Ventilators, BiPAP, and CPAP Machines Recalled Due to Potential Health Risks: FDA Safety Communication

The recall is due to issues with PE-PUR foam, used to reduce sound and vibration, breaking down and potentially entering the device’s air pathway.
Read more: Certain Philips Respironics Ventilators, BiPAP, and CPAP Machines Recalled Due to Potential Health Risks: FDA Safety Communication

Pharma Reviews: Pharmaceutical Glass Packing Market Value Estimated To Reach US$ 33.2 Billion By 2027 ...

Pharmaceutical packaging can be defined as packaging products made using ... Glass has a vital role in the primary packing of pharmaceutical products. ... of the generic pharmaceutical industry in countries such as China and India ...
Read more: Pharmaceutical Glass Packing Market Value Estimated To Reach US$ 33.2 Billion By 2027 ...

Pharma Reviews: In a first, 5 Indian pharmaceutical majors team up for Molnupiravir trials

The collaboration is a first-of-its-kind for a clinical trial in the Indian pharma industry that is aimed at investigating yet another line of treatment in the ...
Read more: In a first, 5 Indian pharmaceutical majors team up for Molnupiravir trials

US FDA News: FDA Provides Update on Ongoing Efforts to Better Understand the Occurrence of PFAS in the Food Supply

FDA Provides Update on Ongoing Efforts to Better Understand the Occurrence of PFAS in the Food Supply
Read more: FDA Provides Update on Ongoing Efforts to Better Understand the Occurrence of PFAS in the Food Supply

Pharma Reviews: On visit to Novavax facility, Indian ambassador lauds 'robust' Indo-US healthcare cooperation

The Indian envoy has reached out to a large number of pharma companies in the US. His outreach to vaccine manufacturers/firms in the vaccine ...
Read more: On visit to Novavax facility, Indian ambassador lauds 'robust' Indo-US healthcare cooperation

Pharma Reviews: Lupin gets USFDA nod for HIV drug under PEPFAR

AstraZeneca Pharma India moves Delhi High Court against NPPA demand notice ... The notice of demand alleges that the company has overcharged ...
Read more: Lupin gets USFDA nod for HIV drug under PEPFAR

Pharma Reviews: FMCG, private banks, pharma underperform Nifty in H1CY21, top analysts track the road ahead

The Indian market has made healthy gains in the first half of the calendar year 2021, with most sectoral indices logging double-digit gains. But sectors ...
Read more: FMCG, private banks, pharma underperform Nifty in H1CY21, top analysts track the road ahead

Pharma Reviews: Stock Market Live Updates: Sensex trades higher, Nifty above 15800 led by IT, metal stocks

Stock Market Live Updates: The Indian equity indices, Sensex and Nifty are ... Pharma Majors - Cipla, Dr Reddy's, Sun Pharma, Torrent Pharma and ...
Read more: Stock Market Live Updates: Sensex trades higher, Nifty above 15800 led by IT, metal stocks

Pharma Reviews: Sputnik V shot around 90% effective against Delta, claim developers

In a first, five Indian pharma majors have joined hands to conduct phase-III clinical trials of investigational anti-viral drug Molnupiravir on mild Covid-19 ...
Read more: Sputnik V shot around 90% effective against Delta, claim developers

Pharma Reviews: Coronavirus News LIVE Updates: COVID-19 third wave likely to be less severe for Mumbai, 80 ...

Coronavirus LIVE Updates: India saw a single day rise of 45,951 ... In a first of kind its initiative, five large Indian pharmaceutical companies Cipla, ...
Read more: Coronavirus News LIVE Updates: COVID-19 third wave likely to be less severe for Mumbai, 80 ...

Pharma Reviews: For The First Time, 5 Indian Drug Makers Are Collaborating For Trials Of An Oral COVID-19 Drug

Five major Indian pharma companies, Cipla Limited, Dr. Reddy's Laboratories, Emcure Pharmaceuticals, Sun Pharmaceutical Industries and Torrent ...
Read more: For The First Time, 5 Indian Drug Makers Are Collaborating For Trials Of An Oral COVID-19 Drug

Pharma Reviews: Market LIVE Update: Sensex up over 250 pts, Nifty above 15800; PSU banks gain

Indian indices surged over 0.46% on Wednesday. Asian markets ... Yash Gupta equity research associate, Angel Broking on pharma sector. Pharma ...
Read more: Market LIVE Update: Sensex up over 250 pts, Nifty above 15800; PSU banks gain

Pharma Reviews: AstraZeneca Pharma India moves Delhi High Court against NPPA demand notice

The notice of demand alleges that the company has overcharged about Rs 157.38 crore during the period from March 8, 2019 to January 31, 2021 in ...
Read more: AstraZeneca Pharma India moves Delhi High Court against NPPA demand notice

Pharma Reviews: In a first, 5 Indian pharma majors ally for Covid drug trials

According to the companies, the collaboration is a first-of-its-kind for a clinical trial in the Indian pharma industry that is aimed at investigating yet ...
Read more: In a first, 5 Indian pharma majors ally for Covid drug trials

Pharma Reviews: Cipla gets DCGI nod to import Moderna's Covid vaccine for restricted emergency use in India ...

India's drug regulator DCGI has granted permission to Mumbai-based pharmaceutical company Cipla to import Moderna's COVID-19 vaccine for ...
Read more: Cipla gets DCGI nod to import Moderna's Covid vaccine for restricted emergency use in India ...

US FDA News: Coronavirus (COVID-19) Update: June 29, 2021

The FDA has sent to Congress its Report on Drug Shortages for Calendar Year 2020, which includes a section on the agency’s drug shortage efforts in response to COVID-19. The FDA is also working to implement the drug shortage-related provisions of the Coronavirus Aid, Relief, & Economic Security Act.
Read more: Coronavirus (COVID-19) Update: June 29, 2021

Pharma Reviews: Parsing The Physician's Prescription Under The Competition Law Lens

The inherently existing information asymmetry in the pharmaceutical industry in India is aggravated by the nature of the anti-trust laws. I will use the test ...
Read more: Parsing The Physician's Prescription Under The Competition Law Lens

Pharma Reviews: It's time India's drug controller confronts key questions on quality control & enforcement

Which is why, they say, we no more hear of the stories like the raids on Delhi's Bhagirath Palace, a wholesale market for drugs and medical equipment ...
Read more: It's time India's drug controller confronts key questions on quality control & enforcement

Pharma Reviews: Bajaj Healthcare shares surge as co moves patent office to seek compulsory licence for Baricitinib

Shares of Drug firm Bajaj Healthcare surged around 14% in Tuesday's early deals after the company on Monday said it has moved the Indian Patent ...
Read more: Bajaj Healthcare shares surge as co moves patent office to seek compulsory licence for Baricitinib

Pharma Reviews: Dr Reddy's says 'slight' delay in commercial rollout of Sputnik V vaccine

Around three million doses of Sputnik have arrived in India and the ... a speedier rollout before Indian pharma companies start producing Sputnik V.
Read more: Dr Reddy's says 'slight' delay in commercial rollout of Sputnik V vaccine

Pharma Reviews: IT a better defensive pick; don't go overweight on pharma: Ajay Bagga

These are priced to perfection, says market expert Ajay Bagga. Do you believe ... One cannot expect blockbuster drugs from Indian pharma. We see a ...
Read more: IT a better defensive pick; don't go overweight on pharma: Ajay Bagga

Pharma Reviews: IICT ties up with Nosch Labs for transfer of process knowhow to make anti-Covid drug 2-DG

... societal challenges and providing innovative solutions to Indian industries in the area of drugs and pharmaceuticals, agrochemicals, lipids, catalysis ...
Read more: IICT ties up with Nosch Labs for transfer of process knowhow to make anti-Covid drug 2-DG

Pharma Reviews: Five Indian pharma giants to collaborate on clinical trials of oral Covid drug Molnupiravir

The five companies are - Cipla Limited, Dr Reddy's Laboratories Ltd, Emcure Pharmaceuticals Ltd, Sun Pharmaceutical Industries and Torrent ...
Read more: Five Indian pharma giants to collaborate on clinical trials of oral Covid drug Molnupiravir

Pharma Reviews: Moderna seeks regulatory approval for its Covid-19 vaccine in India

Mumbai-based pharmaceutical firm Cipla, on behalf of the US pharma major, has requested for import and marketing authorisation of these jabs.
Read more: Moderna seeks regulatory approval for its Covid-19 vaccine in India

Pharma Reviews: Covid: In a first, 5 Indian pharma majors join hands for Molnupiravir clinical trials

HYDERABAD: In a first such instance of collaboration in the pharma sector, five Indian pharma majors – Cipla Ltd, Dr Reddy's Laboratories Ltd, Sun ...
Read more: Covid: In a first, 5 Indian pharma majors join hands for Molnupiravir clinical trials

Pharma Reviews: Domestic pharma majors join hands for clinical trial of Covid treatment drug

Such collaboration for a clinical trial is a first of its kind within the Indian pharma industry, and will aim to investigate yet another line of treatment in the ...
Read more: Domestic pharma majors join hands for clinical trial of Covid treatment drug

Pharma Reviews: Mankind Pharma launches Justoza

Delhi, 22nd June, 2021: Mankind Pharma, the 4th largest pharmaceutical company in India has launched Justoza, a Dapagliflozin brand marketed by ...
Read more: Mankind Pharma launches Justoza

Pharma Reviews: Gainers & Losers: 10 stocks that moved most on June 29

Later in the day, there were reports that the pharma major had got the ... In a first of kind its initiative, five large Indian pharmaceutical companies Cipla, ...
Read more: Gainers & Losers: 10 stocks that moved most on June 29

Pharma Reviews: Sun Pharma, Cipla and others partner to conduct trials of COVID-19 antiviral drug Molnupiravir

In a first of kind its initiative, five large Indian pharmaceutical companies Cipla, Dr Reddy's, Emcure, Sun Pharma and Torrent Pharma have joined ...
Read more: Sun Pharma, Cipla and others partner to conduct trials of COVID-19 antiviral drug Molnupiravir

Pharma Reviews: Hyderabad is emerging destination of choice for Life Sciences, Pharma, : Joel Reifman

Telangana has played a very significant role in the Indian Health Care sector by giving the nation the first indigenously developed vaccine by Bharath ...
Read more: Hyderabad is emerging destination of choice for Life Sciences, Pharma, : Joel Reifman

Pharma Reviews: Exclusive interview: THB co-founder and CEO Akansh Khurana

Recently, Health Issues India had the opportunity to interview Mr Akansh Khurana, ... labs, pharmaceutical companies, insurance companies, and organisations ... We enable our customers to deliver evidence-based medicine, and ...
Read more: Exclusive interview: THB co-founder and CEO Akansh Khurana

Pharma Reviews: Building authentication eco-systems is crucial to prevent falsified medicines, say pharma experts

Providing an overview of the counterfeiting issue in India, Nakul Pasricha, President, ASPA said, "Every year, the global pharmaceutical supply chain ...
Read more: Building authentication eco-systems is crucial to prevent falsified medicines, say pharma experts

Pharma Reviews: Centre plans to set up national stockpile of drugs, medical equipment to tackle COVID-19 third wave

It will also help in strengthening the supply chain and resolve possible glitches in the manufacturing process. Indian Pharmaceutical Alliance Secretary ...
Read more: Centre plans to set up national stockpile of drugs, medical equipment to tackle COVID-19 third wave

Pharma Reviews: PLI Scheme Holds Promise For Pharma, Execution & Scale Of Benefits Critical

India Ratings and Research (Ind-Ra) expects the production-linked Incentive (PLI) scheme could be a growth driver for the pharmaceutical sector in ...
Read more: PLI Scheme Holds Promise For Pharma, Execution & Scale Of Benefits Critical

Pharma Reviews: Market LIVE Update: Sensex sheds 200 pts, Nifty above 15700; banks top drags

Indian indices were down on Tuesday with pharma stocks being outliers on account of the FM's allocation of ₹50,000 crore to health infra on Monday.
Read more: Market LIVE Update: Sensex sheds 200 pts, Nifty above 15700; banks top drags

Pharma Reviews: The demand for faster and better drug development will accelerate the adoption of machine ...

The pandemic has demonstrated that the Indian pharma industry has a key role to play in global healthcare needs and access to medicines. Shahid ...
Read more: The demand for faster and better drug development will accelerate the adoption of machine ...

Pharma Reviews: Govt plans nat'l stockpile of life-saving drugs

The stockpile will help companies to plan and manage inventory to ... Indian Pharmaceutical Alliance secretary general Sudarshan Jain told TOI.
Read more: Govt plans nat'l stockpile of life-saving drugs

Pharma Reviews: Govt plans national stockpile of life-saving drugs

... to be important in the unpredictable environment on account of Covid," Indian Pharmaceutical Alliance secretary general Sudarshan Jain told TOI.
Read more: Govt plans national stockpile of life-saving drugs

Pharma Reviews: Bajaj Healthcare requests Indian patent office to grant compulsory licence for COVID-19 drug

The firm approached the Indian Patent Office after Eli Lilly & Company on two occasions declined to sign the voluntary licence for manufacturing and ...
Read more: Bajaj Healthcare requests Indian patent office to grant compulsory licence for COVID-19 drug

Pharma Reviews: Bajaj Healthcare moves Indian patent office for compulsory licence for Covid drug

The company had approached Eli Lilly & Company on two occasions to sign the voluntary licence for manufacturing and supply of Baricitinib and had ...
Read more: Bajaj Healthcare moves Indian patent office for compulsory licence for Covid drug

Pharma Reviews: Stay invested! Globally, biggest bull runs occurred when GDP moves towards $5 trillion

Indian IT Services companies such as Wipro and TCS which are part of the ... (CRAMS) are two areas in pharma and healthcare where Indian companies will ... The healthcare diagnostics market in India is quite fragmented with ...
Read more: Stay invested! Globally, biggest bull runs occurred when GDP moves towards $5 trillion

Pharma Reviews: Quadria Capital to buy 15% stake in Encube Ethicals valuing firm at $800 million; Multiples PE To ...

In 2019, Quadria Capital, an Asia focused healthcare private equity firm had invested in Akums Drugs & Pharmaceuticals, India's single largest ...
Read more: Quadria Capital to buy 15% stake in Encube Ethicals valuing firm at $800 million; Multiples PE To ...

Pharma Reviews: Market LIVE Updates: Indices flat after begins trade at record high; PSU bank, metal stocks gain

Indian rupee opened marginally lower at 74.25 per dollar Monday on ... Among the sectors, pharma and PSU Bank added a percent each while IT ...
Read more: Market LIVE Updates: Indices flat after begins trade at record high; PSU bank, metal stocks gain

Pharma Reviews: Carbon window closure: Heed the swing and follow-through

Take the pharma sector. As the largest generic manufacturer, and 50% manufacturer of all vaccines, India is often called the pharmacy of the world.
Read more: Carbon window closure: Heed the swing and follow-through

Pharma Reviews: Industry Knowledge eXchange: Foundation Excellence – Network and Spend Optimization

Express Pharma, first published as Express Pharma Pulse in 1994, is today India's leading business fortnightly for the pharmaceutical industry.
Read more: Industry Knowledge eXchange: Foundation Excellence – Network and Spend Optimization

Pharma Reviews: Haryana govt working towards developing State into pharma hub: CM Manohar Lal Khattar

... will be given for setting up pharma industries in Haryana," he said presiding over a meeting with the Confederation of Indian Industry (CII). The chief ...
Read more: Haryana govt working towards developing State into pharma hub: CM Manohar Lal Khattar

Pharma Reviews: First acquisition of listed firm by Indian unicorn: Pharmeasy picks up 66.1% in Thyrocare

PharmEasy is an online pharmacy and diagnostics brand, RetailIO – India's largest B2B pharma marketplace & seller, and DocOn – a leading ...
Read more: First acquisition of listed firm by Indian unicorn: Pharmeasy picks up 66.1% in Thyrocare

Pharma Reviews: Haryana to be developed as Pharma hub through MSMEs: Manohar Lal Khattar

While speaking during a meeting with the Confederation of Indian Industry (CII) here virtually on Friday, the Chief Minister also said that special ...
Read more: Haryana to be developed as Pharma hub through MSMEs: Manohar Lal Khattar

Pharma Reviews: State as pharmaceutical hub! Haryana focusing to boost MSMEs

... with the Confederation of Indian Industry (CII) here virtually, he said special incentives would be given for setting up pharmaceutical industries.
Read more: State as pharmaceutical hub! Haryana focusing to boost MSMEs

US FDA News: Coronavirus (COVID-19) Update: June 25, 2021

Coronavirus (COVID-19) Update
Read more: Coronavirus (COVID-19) Update: June 25, 2021

US FDA News: Smiths Medical Recalls Jelco Hypodermic Needle-Pro Fixed Needle Insulin Syringes for Skewed Graduated Marks on Syringe Barrel That May Cause Insulin Overdose or Underdose

Jelco Hypodermic Needle-Pro Fixed Needle Insulin Syringes deliver U-100 insulin. Skewed markings on the syringe barrel may lead to insulin overdose or underdose.
Read more: Smiths Medical Recalls Jelco Hypodermic Needle-Pro Fixed Needle Insulin Syringes for Skewed Graduated Marks on Syringe Barrel That May Cause Insulin Overdose or Underdose

US FDA News: Avid Medical Recalls Medical Convenience Kits for Risk of Fungal Contamination

Medical convenience kits group devices together for medical providers. Kits contain ChloraPrep 3mL, which is under recall for fungal contamination risk
Read more: Avid Medical Recalls Medical Convenience Kits for Risk of Fungal Contamination

US FDA News: DeRoyal Industries Recalls Surgical Procedure Packs for Mislabeled Lidocaine

Surgical procedure packs group devices together for medical providers. Packs contain Hospira Pfizer 1% lidocaine which may be mislabeled as bupivacaine.
Read more: DeRoyal Industries Recalls Surgical Procedure Packs for Mislabeled Lidocaine

US FDA News: Flexible Bronchoscopes and Updated Recommendations for Reprocessing: FDA Safety Communication

Failure to correctly follow manufacturer instructions for reprocessing and device maintenance can potentially result in infection transmission.
Read more: Flexible Bronchoscopes and Updated Recommendations for Reprocessing: FDA Safety Communication

Pharma Reviews: Has India's economic warfare against China post Galwan clash worked?

“This is the first time India has adopted economic warfare as a policy,” ... or raw materials that go into making medicines by India's pharma companies), ...
Read more: Has India's economic warfare against China post Galwan clash worked?

Pharma Reviews: Working to develop Haryana into hub of pharma industry: Khattar

... incentives will be given for setting up pharma industries in Haryana," he said presiding over a meeting with the Confederation of Indian Industry (CII) ...
Read more: Working to develop Haryana into hub of pharma industry: Khattar

US FDA News: Coronavirus (COVID-19) Update: FDA Authorizes Drug for Treatment of COVID-19

The FDA authorized a drug for the treatment for the treatment of COVID-19 in hospitalized adults and pediatric patients who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO).
Read more: Coronavirus (COVID-19) Update: FDA Authorizes Drug for Treatment of COVID-19

US FDA News: FDA In Brief: FDA Encourages Inclusion of Patients with Incurable Cancers in Oncology Clinical Trials Regardless of Prior Therapies

FDA released new draft guidance encouraging broadening clinical trials eligibility criteria to include patients with incurable cancers, regardless of prior therapies.
Read more: FDA In Brief: FDA Encourages Inclusion of Patients with Incurable Cancers in Oncology Clinical Trials Regardless of Prior Therapies

Pharma Reviews: India: Pharmaceutical Industry And Intellectual Property Rights – An Indian Perspective

The pharmaceutical industry particularly accounts for majority of the trademark registrations as compared to any other sector in India. Protection of drugs ...
Read more: India: Pharmaceutical Industry And Intellectual Property Rights – An Indian Perspective

Pharma Reviews: Market LIVE Update: Sensex gains over 300 pts, Nifty above 15700; IT gains

Indian indices opened in green on Thursday. ... Hospital business has done well for the company and pharmacy business was flat for the quarter ...
Read more: Market LIVE Update: Sensex gains over 300 pts, Nifty above 15700; IT gains

Pharma Reviews: 3 Pharma Stocks To Watch Out For

However, Indian pharmaceutical businesses have always had a positive reputation in the global pharmaceutical market. Indian Pharma companies have ...
Read more: 3 Pharma Stocks To Watch Out For

Pharma Reviews: Stock Market Live Updates: Sensex, Nifty trade flat amid volatility; Auto, PSU banks gain; IT, FMCG ...

Stock Market Live Updates: The Indian equity indices, Sensex and Nifty are ... “Therefore, given the valuations are for the pharma sector and for the ...
Read more: Stock Market Live Updates: Sensex, Nifty trade flat amid volatility; Auto, PSU banks gain; IT, FMCG ...

Pharma Reviews: Airtel-Tata 5G Tie-Up Is A Positive For Atmanirbharta; We Need More Such Collaborations

Indian companies need to change mindsets where they should consider formal ... support and collaboration between large Indian pharma companies.
Read more: Airtel-Tata 5G Tie-Up Is A Positive For Atmanirbharta; We Need More Such Collaborations

Pharma Reviews: Market LIVE Updates: Indices trade flat amid volatility; UBL in focus on Heineken's additional stake ...

Market LIVE Updates: Indices trade flat amid volatility; UBL in focus on ... In March, 2021, Piramal Pharma Ltd entered into an agreement to acquire 100% ... Indian rupee erased early gains and trading flat at 74.35 per dollar, amid ...
Read more: Market LIVE Updates: Indices trade flat amid volatility; UBL in focus on Heineken's additional stake ...

Pharma Reviews: LogoNext Level Innovations in Pharmaceutical Industry: – Genomics, Gene Editing, Artificial ...

Dr. SD Gupta, Trustee Secretary, IIHMR University, Chief Guest, Mr. Sudarshan Jain, Secretary General, Indian Pharmaceutical Alliance; Former MD, ...
Read more: LogoNext Level Innovations in Pharmaceutical Industry: – Genomics, Gene Editing, Artificial ...

US FDA News: Coronavirus (COVID-19) Update: June 22, 2021

The FDA issued a Drug Safety Communication for hand sanitizers, warning that symptoms such as headache, nausea, and dizziness can occur after applying alcohol-based hand sanitizers to the skin and inhaling the vapors that linger; and issued a warning letter to a company selling an unapproved product
Read more: Coronavirus (COVID-19) Update: June 22, 2021

US FDA News: Sanit Technologies Adds Label Clarification to Existing Voluntary Hand Sanitizer Recall

Sanit Technologies LLC d/b/a Durisan, is providing an additional 5 label illustrations and product sizes for customers that might not have been able to clearly identify containers of Non-Alcohol Hand Sanitizer products that were added to the voluntary recall initiated on March 24, 2021, and expanded
Read more: Sanit Technologies Adds Label Clarification to Existing Voluntary Hand Sanitizer Recall

US FDA News: Prairie Wolf Spirits, Inc. Issues Voluntary Nationwide Recall of Prairie Wolf Distillery Hand Sanitizer Packed in 16.9 Oz. and 20 Oz Bottles Because They Resemble Drink Containers

Oklahoma City, Oklahoma, Prairie Wolf Spirits, Inc. is voluntarily recalling all lots of Prairie Wolf Distillery hand sanitizer packaged in 16.9 fluid ounce and 20 fluid ounce containers that resemble water bottles to the consumer level. The recall does not affect any other hand sanitizer product
Read more: Prairie Wolf Spirits, Inc. Issues Voluntary Nationwide Recall of Prairie Wolf Distillery Hand Sanitizer Packed in 16.9 Oz. and 20 Oz Bottles Because They Resemble Drink Containers

Pharma Reviews: Next level innovations in pharmaceutical industry: experts at IIHMR University's Pharma Conclave ...

Dr SD Gupta, Trustee Secretary, IIHMR University, Chief Guest, Sudarshan Jain, Secretary-General, Indian Pharmaceutical Alliance; Former MD, ...
Read more: Next level innovations in pharmaceutical industry: experts at IIHMR University's Pharma Conclave ...

Pharma Reviews: Market LIVE Update: Sensex, Nifty off day's high; FMCG drags; metals shine

Subject expert committee of the Central Drugs Standards Control Organisation will meet today, according to Redbox India. The committee will review the ...
Read more: Market LIVE Update: Sensex, Nifty off day's high; FMCG drags; metals shine

Pharma Reviews: IRM India Affiliate to strengthen risk-readiness in the Indian Pharmaceutical Sector

As the largest provider of generic drugs worldwide, and with over 50% market share in the vaccines segment, India is a vital part of the global pharma ...
Read more: IRM India Affiliate to strengthen risk-readiness in the Indian Pharmaceutical Sector

Pharma Reviews: Indian Enterprises Accelerate their Pace to Become Future Ready with 'RISE with SAP'

This will enable us to build a strong foundation in India's pharmaceutical industry and support our vision of providing quality, affordable and innovative ...
Read more: Indian Enterprises Accelerate their Pace to Become Future Ready with 'RISE with SAP'

US FDA News: FDA Approves First Oral Blood Thinning Medication for Children

Today, the FDA approved Pradaxa oral pellets and capsules to treat children with blood clots directly after they have been treated with a blood thinner given by injection for at least five days, and to prevent recurrent clots among patients who completed treatment for their first clot.
Read more: FDA Approves First Oral Blood Thinning Medication for Children

Pharma Reviews: Industry leaders, top govt officials to participate in India-US Pharma Summit

Washington: Top government officials, leaders from the industry and academicians from India and the US would take part in the annual India-US ...
Read more: Industry leaders, top govt officials to participate in India-US Pharma Summit

Pharma Reviews: Scope of Indian Certification of Medical Devices scheme expanded by QCI

Adil Zainulbhai, Chairman, QCI, said that the agility of the Indian medical device manufacturers to respond effectively to the COVID pandemic ...
Read more: Scope of Indian Certification of Medical Devices scheme expanded by QCI

Pharma Reviews: Urgently trying to work with AstraZeneca, SII, Indian govt to restart COVID-19 vaccine shipments ...

Pharmaceutical major Zydus Cadila has told the Centre that it could apply for emergency use authorisation (EUA) for ZyCoV-D vaccine in the next seven ...
Read more: Urgently trying to work with AstraZeneca, SII, Indian govt to restart COVID-19 vaccine shipments ...

Pharma Reviews: US to invest over $3 billion for Covid antiviral medicines

Top government officials, leaders from industry, academicians to take part in India-US Biopharma and Healthcare Summit. NITI Aayog CEO Amitabh ...
Read more: US to invest over $3 billion for Covid antiviral medicines

Pharma Reviews: Top government officials, leaders from industry, academicians to take part in India-US Biopharma ...

NITI Aayog CEO Amitabh Kant, Pfizer CEO Dr Alberta Bourla, National Institutes of Health (NIH) Director Dr Francis Collins and Food and Drug ...
Read more: Top government officials, leaders from industry, academicians to take part in India-US Biopharma ...

Pharma Reviews: Zydus Cadila likely to seek emergency use authorisation for its Covid vaccine next week

Venus Remedies challenged the Indian patent by the French pharmaceutical giant SCR Pharmatop in 2011 after prompted by an attempted drug patent ...
Read more: Zydus Cadila likely to seek emergency use authorisation for its Covid vaccine next week

Pharma Reviews: Stock Market Highlights: Sensex, Nifty recover losses to end flat; small, midcaps underperform

Stock Market Highlights: Indian equity indices, Sensex and Nifty recovered from ... Selling was seen in PSU Banks, metal, IT, auto and pharma indices.
Read more: Stock Market Highlights: Sensex, Nifty recover losses to end flat; small, midcaps underperform

Pharma Reviews: Emcure says it will continue growth momentum in FY21 by deepening product portfolio, digital focus

The Indian pharmaceutical market, in the same period, grew at 2.1 percent. AIOCD is a pharmaceutical market research company, which tracks the sales ...
Read more: Emcure says it will continue growth momentum in FY21 by deepening product portfolio, digital focus

Pharma Reviews: Venus Remedies wins decade long battle against French firm to cancel Indian patent for ...

New Delhi: In a historical breakthrough for the pharmaceutical industry in India, Himachal Pradesh-based Venus Remedies has won a 10-year long ...
Read more: Venus Remedies wins decade long battle against French firm to cancel Indian patent for ...

Pharma Reviews: Indian Pharma Industry - PLI Scheme To Help India Become Aatmanirbhar In APIs: ICRA

High value-add pharmaceutical products are generally research and development intensive and difficult to manufacture products and include products ...
Read more: Indian Pharma Industry - PLI Scheme To Help India Become Aatmanirbhar In APIs: ICRA

Pharma Reviews: 'Pandemic's unprecedented situation has brought the Medtech industry to the fore of healthcare ...

Covid-19 has once again brought Indian medtech to the epicentre. The current pandemic has led the medical devices industry to quickly recalibrate ...
Read more: 'Pandemic's unprecedented situation has brought the Medtech industry to the fore of healthcare ...

Pharma Reviews: Novavax's Covid-19 vaccine 'Covavax' to launch in India by September: Sources

The Serum Institute of India (SII) hopes to introduce US firm Novavax's ... Meanwhile, the All India Institute of Medical Sciences (AIIMS) in Delhi from ...
Read more: Novavax's Covid-19 vaccine 'Covavax' to launch in India by September: Sources

Pharma Reviews: Indian pharma industry sales to log robust growth: Fitch Ratings

The sales for Indian pharmaceutical companies are expected to log a robust growth in FY22, said Fitch Ratings. Chennai: The credit rating agency ...
Read more: Indian pharma industry sales to log robust growth: Fitch Ratings

Pharma Reviews: Bulk Drugs Makers Set For A New Phase Of Growth

The makers of pharma ingredients have announced capacity expansion as ... That came as India looked to boost local manufacturing after a deadly ...
Read more: Bulk Drugs Makers Set For A New Phase Of Growth

US FDA News: Smiths Medical Issues Worldwide Notification Regarding the Recall of Jelco® Hypodermic Needle-Pro® Fixed Needle Insulin Syringe With Skewed Graduation Markings

Smiths Medical has become aware of specific models and lots of Jelco® Hypodermic Needle-Pro® Fixed Needle Insulin Syringes that may exhibit skewed odd number line graduation markings on their syringe barrels. Markings skewed approximately 20 degrees upward have been identified.
Read more: Smiths Medical Issues Worldwide Notification Regarding the Recall of Jelco® Hypodermic Needle-Pro® Fixed Needle Insulin Syringe With Skewed Graduation Markings

Pharma Reviews: Covid-19 has highlighted the Indian pharma industry's potential in transforming into an innovation ...

Shahid Akhter, editor, ETHealthworld, spoke to Sudarshan Jain, Secretary General, Indian Pharmaceutical Alliance, to know more about the pharma ...
Read more: Covid-19 has highlighted the Indian pharma industry's potential in transforming into an innovation ...

Pharma Reviews: Indian Pharma Market - Second Covid-19 Wave, Low Base Drives Growth In May: Prabhudas ...

BQ Blue's special research section collates quality and in-depth equity and economy research reports from across India's top brokerages, asset ...
Read more: Indian Pharma Market - Second Covid-19 Wave, Low Base Drives Growth In May: Prabhudas ...

US FDA News: FDA Approves a Nasal Antihistamine for Nonprescription Use

FDA approved a nasal antihistamine for nonprescription use through a process called a partial prescription to nonprescription switch.
Read more: FDA Approves a Nasal Antihistamine for Nonprescription Use

Pharma Reviews: PLI scheme to help India become Aatmanirbhar in APIs; boost investments in high-value generics ...

ICRA expects the above measures to strengthen the business profile of R&D-based Indian pharma companies and thus an increase in the scale of ...
Read more: PLI scheme to help India become Aatmanirbhar in APIs; boost investments in high-value generics ...

US FDA News: FDA In Brief: FDA Announces Qualification of a Medical Device Development Tool to Help Assess Patient- Reported Outcomes with LASIK Surgery

The FDA qualified a medical device development tool to help assess individuals’ symptoms and satisfaction with vision associated with LASIK surgery.
Read more: FDA In Brief: FDA Announces Qualification of a Medical Device Development Tool to Help Assess Patient- Reported Outcomes with LASIK Surgery

US FDA News: FDA In Brief: FDA Issues Draft Guidance on Remanufacturing and Discussion Paper Seeking Feedback on Cybersecurity Servicing of Medical Devices

The draft guidance should clarify “remanufacturing” and recommendations for labeling devices intended to be serviced over their useful life. A discussion paper outlining cybersecurity challenges and opportunities with the servicing was also released.
Read more: FDA In Brief: FDA Issues Draft Guidance on Remanufacturing and Discussion Paper Seeking Feedback on Cybersecurity Servicing of Medical Devices

Pharma Reviews: Market LIVE Update: Sensex sheds over 100 pts, Nifty at 15.7k; FMCG gains

... by French pharmaceutical firm SCR Pharmatop for producing the intravenous paracetamol solution in India. In a decision dated 4 June, the Indian ...
Read more: Market LIVE Update: Sensex sheds over 100 pts, Nifty at 15.7k; FMCG gains

Pharma Reviews: Indian pharma industry sales to log robust growth: Fitch Ratings

The sales for Indian pharmaceutical companies are expected to log a robust growth in FY22, said Fitch Ratings. The credit rating agency said pharma ...
Read more: Indian pharma industry sales to log robust growth: Fitch Ratings

Pharma Reviews: PHDCCI urges government to extend support for vaccine industry

Therefore, it is critical for the Government of India to support this industry through initiatives like PLI, ... “Despite a total allocation of Rs 21,940 towards the pharmaceuticals sector, the allocation to Indian vaccine manufacturers has not ...
Read more: PHDCCI urges government to extend support for vaccine industry

Pharma Reviews: Pharma firms get quick eco-clearances in Karnataka

After the State Government announced a special industrial cluster in Raichur, most pharma companies have sought environmental clearance for change ...
Read more: Pharma firms get quick eco-clearances in Karnataka

Pharma Reviews: PHDCCI seeks govt support for domestic vaccine industry

... incentive (PLI) scheme announced for the pharmaceutical sector. ... the pharmaceuticals sector, the allocation to Indian vaccine manufacturers has ...
Read more: PHDCCI seeks govt support for domestic vaccine industry

US FDA News: Infusion Pump Repair Recalls Alaris Infusion Pump Module 8100 Bezel Due to Possible Cracked or Separated Bezel Repair Posts

Bezel posts on the Alaris Infusion Pump Module 8100 are critical to pump function. Infusion Pump Repair bezel posts may crack or separate.
Read more: Infusion Pump Repair Recalls Alaris Infusion Pump Module 8100 Bezel Due to Possible Cracked or Separated Bezel Repair Posts

Pharma Reviews: Health Ministry, WHO, JSS AHER, IPA and partners organise virtual workshops series on GMP

... at Mysuru (JSS AHER) and the Indian Pharmaceutical Alliance (IPA). ... South-East Asia, Country Office for India) and leading industry voices came ...
Read more: Health Ministry, WHO, JSS AHER, IPA and partners organise virtual workshops series on GMP

Pharma Reviews: Indian pharma firms sales to rise after resilience in FY21: Fitch Ratings

Mumbai: Indian pharmaceutical companies' sales will grow robustly in the financial year ending March 2022 (FY22) as sales normalise in categories ...
Read more: Indian pharma firms sales to rise after resilience in FY21: Fitch Ratings

Pharma Reviews: Kiran Mazumdar Says COVID-19 Has Created An “Ecosystem” Of Innovation In India

Kiran Mazumdar COVID remark: Ahead of the annual India-US bio-pharma ... has also partnered with the same company for vaccine manufacture.
Read more: Kiran Mazumdar Says COVID-19 Has Created An “Ecosystem” Of Innovation In India

US FDA News: Coronavirus (COVID-19) Update: June 15, 2021

Coronavirus (COVID-19) Update: June 15, 2021
Read more: Coronavirus (COVID-19) Update: June 15, 2021

US FDA News: Philips Issues a Recall Notification* to Mitigate Potential Health Risks Related to the Sound Abatement Foam Component in Certain Sleep and Respiratory Care Devices

Following the company update on April 26, 2021, Royal Philips(NYSE: PHG; AEX: PHIA) today provides an update on the recall notification* for specific Philips Bi-Level Positive Airway Pressure (Bi-Level PAP), Continuous Positive Airway Pressure (CPAP), and mechanical ventilator devices to address ide
Read more: Philips Issues a Recall Notification* to Mitigate Potential Health Risks Related to the Sound Abatement Foam Component in Certain Sleep and Respiratory Care Devices

US FDA News: FDA Approves StrataGraft for the Treatment of Adults with Thermal Burns

FDA approved StrataGraft for the treatment of adult patients with thermal burns containing intact dermal elements (remaining deep skin layers) for which surgical intervention is clinically indicated (also referred to as deep partial thickness burns).
Read more: FDA Approves StrataGraft for the Treatment of Adults with Thermal Burns

Pharma Reviews: MoH&FW's virtual workshop on cGMP for Indian pharma industry held

Health Ministry has collaborated with WHO, JSS AHER, Indian Pharmaceutical Alliance and partners provide a unique learning platform.
Read more: MoH&FW's virtual workshop on cGMP for Indian pharma industry held

Pharma Reviews: The Journey of Big Data in India and its Future Ahead

R&D centers and pharma companies are using data analytics for drug development. Using predictive models and statistical tools for drug discovery has ...
Read more: The Journey of Big Data in India and its Future Ahead

Pharma Reviews: Making India's Pharmaceutical Industry Future Ready

Making India's Pharmaceutical Industry Future Ready. Health Ministry, WHO, JSS AHER, Indian Pharmaceutical Alliance and partners organizing a ...
Read more: Making India's Pharmaceutical Industry Future Ready

Pharma Reviews: Rs 150 per Covaxin dose to Centre not sustainable in long run: Bharat Biotech

In the absence of a dual pricing system, Indian vaccine and pharmaceutical companies risk being reduced to mere contract manufacturers with ...
Read more: Rs 150 per Covaxin dose to Centre not sustainable in long run: Bharat Biotech

Pharma Reviews: Exclusive: Indian envoy says if health situation permits, PM Modi will visit US before year-end

INDUSTRY. The US private sector has been very forthcoming to assist in India's efforts to confront the pandemic. Significant announcements of medical ...
Read more: Exclusive: Indian envoy says if health situation permits, PM Modi will visit US before year-end

Pharma Reviews: Existing lacunae in pharma education and how to fill them

The need for pharmacists is further growing with the growth of the pharmaceutical industry in India. To grab the emerging opportunities in the pharma ...
Read more: Existing lacunae in pharma education and how to fill them

Pharma Reviews: Covid has created an ecosystem of innovation in India: Kiran Mazumdar-Shaw

They (the Indian pharma companies) were limited in terms of their vaccine capacity because of some of these constraints. But now with the US opening ...
Read more: Covid has created an ecosystem of innovation in India: Kiran Mazumdar-Shaw

Pharma Reviews: No plans to get into vaccine production as it requires separate manufacturing infra: Sun Pharma

On the biosimilar front, he noted that the drug firm is looking to develop a range of such products. "We are evaluating development of some biosimilars ...
Read more: No plans to get into vaccine production as it requires separate manufacturing infra: Sun Pharma

Pharma Reviews: India and Kenya discuss possibility of JVs in pharma manufacturing

On its part, Kenya welcomed Indian investments in manufacturing, agro-processing, pharmaceuticals, automobile and affordable housing. MORE FROM ...
Read more: India and Kenya discuss possibility of JVs in pharma manufacturing

Pharma Reviews: Training healthcare workers and pharmacists against fraudulent medicines is a must: ASPA

He reveals more about India's fight against counterfeit drugs to Akanki ... from the Indian Nursing Council (INC), Indian Pharmaceutical Association ...
Read more: Training healthcare workers and pharmacists against fraudulent medicines is a must: ASPA

Pharma Reviews: This portfolio manager sees massive earnings uptick in mid and smallcaps

Investors should be looking at sectors like pharma, on which we have been bullish for the last eight to 10 months and I believe the Indian API industry ...
Read more: This portfolio manager sees massive earnings uptick in mid and smallcaps

Pharma Reviews: “Vaccine & biological therapies are expected to increase investment in R&D to create demand in ...

Besides, we continued supporting commercial drug product manufacturing ... What are the future trends & challenges of the CDMO industry in India?
Read more: “Vaccine & biological therapies are expected to increase investment in R&D to create demand in ...

Pharma Reviews: Natco Pharma's marketing partner gets USFDA nod for anti-cancer drug

Natco Pharma is an Indian multinational pharmaceutical company based in Hyderabad. The company is engaged in developing, manufacturing and ...
Read more: Natco Pharma's marketing partner gets USFDA nod for anti-cancer drug

Pharma Reviews: Market LIVE Update: Sensex slips over 150 pts, Nifty above 15725; VIX at 6.52%

Indian pharmaceutical companies' sales will grow robustly in the financial year ending March 2022 (FY22) as sales normalise in categories affected ...
Read more: Market LIVE Update: Sensex slips over 150 pts, Nifty above 15725; VIX at 6.52%

Pharma Reviews: SVKM's NMIMS Opens Admissions for Integrated B. Pharm. + MBA (Pharma. Tech.) Program

The Indian pharmaceutical sector is a rapidly growing industry with a need for skilled professionals who have the ability to understand and navigate ...
Read more: SVKM's NMIMS Opens Admissions for Integrated B. Pharm. + MBA (Pharma. Tech.) Program

Pharma Reviews: Why big pharma had a responsibility to profit from the pandemic

However, questions arise as to whether or not this is moral and ethical. Pharmaceutical companies have a responsibility towards their business and ...
Read more: Why big pharma had a responsibility to profit from the pandemic

Pharma Reviews: Biophore seeks DCGI emergency use nod for Aviptadil for treating Covid-19

New Delhi: Biophore India Pharmaceuticals has recently announced that the company has applied for DCGI emergency use approval of Aviptadil ...
Read more: Biophore seeks DCGI emergency use nod for Aviptadil for treating Covid-19

Pharma Reviews: More and more organisations in India understand and have diversity, equity and inclusion as a key ...

I think the pharma sector and the GBOs are undergoing a huge transformation and COVID-19 has been one of the determining factors along with price ...
Read more: More and more organisations in India understand and have diversity, equity and inclusion as a key ...

Pharma Reviews: Biophore applies for DCGI Emergency use approval of Aviptadil for COVID-19

Hyderabad-based Biophore India Pharmaceuticals on Friday announced it ... The company was one of the first few manufacturers to have received ...
Read more: Biophore applies for DCGI Emergency use approval of Aviptadil for COVID-19

Pharma Reviews: Russia Day 2021: And quiet flows the Volga... A review of India-Russia relations

In fact, most of the pharmaceutical entrepreneurs in India acknowledge the immense role of Russia in sharing their expertise with Indians. Even today ...
Read more: Russia Day 2021: And quiet flows the Volga... A review of India-Russia relations

US FDA News: Viona Pharmaceuticals Inc., Issues Voluntary Nationwide Recall of Metformin HCl Extended-Release Tablets, USP 750 mg, Due to the Detection of N-Nitrosodimethylamine (NDMA) Impurity

Viona Pharmaceuticals Inc., is voluntarily recalling 2 (two) lots of Metformin Hydrochloride Extended-Release Tablets, USP 750 mg to the retail level.
Read more: Viona Pharmaceuticals Inc., Issues Voluntary Nationwide Recall of Metformin HCl Extended-Release Tablets, USP 750 mg, Due to the Detection of N-Nitrosodimethylamine (NDMA) Impurity

US FDA News: Coronavirus (COVID-19) Update: June 11, 2021

Coronavirus (COVID-19) Update: June 11, 2021
Read more: Coronavirus (COVID-19) Update: June 11, 2021

US FDA News: FDA Takes Steps to Increase Availability of COVID-19 Vaccine

FDA authorized two batches of Janssen’s COVID-19 vaccine drug substance manufactured at the Emergent BioSolutions facility in Baltimore
Read more: FDA Takes Steps to Increase Availability of COVID-19 Vaccine

Pharma Reviews: How Pharma Regulators, Companies & Physicians Can Collaborate To Win COVID War?

Indian biopharma industry has been in an overdrive to create new viable vaccine candidates (Bharat Biotech, Zydus Cadila), to bring leading foreign ...
Read more: How Pharma Regulators, Companies & Physicians Can Collaborate To Win COVID War?

Pharma Reviews: Alkem Labs launches epilepsy drug Perampil in India

Alkem Labs launches epilepsy drug Perampil in India ... of quality products to patients and health care professionals in India," the company stated.
Read more: Alkem Labs launches epilepsy drug Perampil in India

Pharma Reviews: CSIR-IICT ties up with Suven Pharma for new anti-Covid drug Molnupiravir

In what comes as a boost to India's pharmaceutical industry amid the coronavirus disease (Covid-19) pandemic, the Council of Scientific and Industrial ...
Read more: CSIR-IICT ties up with Suven Pharma for new anti-Covid drug Molnupiravir

Pharma Reviews: Mankind Pharma Launches DCGI Approved Posaforce 100 Drug For Black Fungus Treatment

Indian pharmaceutical company, Mankind Pharma on Thursday informed that it has launched Posaconazole Gastro-resistant tablets, used to treat ...
Read more: Mankind Pharma Launches DCGI Approved Posaforce 100 Drug For Black Fungus Treatment

Pharma Reviews: Biophore applies for DCGI Emergency use approval of Aviptadil for COVID-19

... Jun 11 (UNI) Hyderabad-based Biophore India Pharmaceuticals on Friday ... The company was one of the first few manufacturers to have received ...
Read more: Biophore applies for DCGI Emergency use approval of Aviptadil for COVID-19

US FDA News: Sodium Citrate Blood Specimen Collection Tube Conservation Strategies – Letter to Health Care and Laboratory Personnel

Sodium Citrate Blood Specimen Collection Tube Conservation Strategies
Read more: Sodium Citrate Blood Specimen Collection Tube Conservation Strategies – Letter to Health Care and Laboratory Personnel

US FDA News: Innova Medical Group Recalls Unauthorized SARS-CoV-2 Antigen Rapid Qualitative Test with Risk of False Test Results

Innova SARS-CoV-2 Antigen Rapid Qualitative Test performance characteristics have not been adequately established, presenting a risk of false results.
Read more: Innova Medical Group Recalls Unauthorized SARS-CoV-2 Antigen Rapid Qualitative Test with Risk of False Test Results

US FDA News: Stop Using Innova SARS-CoV-2 Antigen Rapid Qualitative Test: FDA Safety Communication

The FDA has significant concerns that performance of the test has not been adequately established, presenting a risk to health.
Read more: Stop Using Innova SARS-CoV-2 Antigen Rapid Qualitative Test: FDA Safety Communication

Pharma Reviews: Is the global pharma industry unhappy with India's policies?

Indian pharma industry will gain immensely and our country will stand out as ... The Drugs Controller General of India, on January 3, granted restricted ...
Read more: Is the global pharma industry unhappy with India's policies?

Pharma Reviews: DRDO invites Indian pharma firms for bulk production of COVID drug 2DG

... for Transfer of Technology (ToT) related to the Covid-19 drug, 2-Deoxy-D-Glucose (2-DG) to Indian pharmaceutical industries for bulk production.
Read more: DRDO invites Indian pharma firms for bulk production of COVID drug 2DG

Pharma Reviews: Sensex up 393 pts at close, Nifty at 15744; realty, pharma top gainers

Market closing. Benchmark Indian equity indices were up 0.65% at close on Thursday. The Sensex closed at 52,300.47, up 358.83 points, or 0.69% ...
Read more: Sensex up 393 pts at close, Nifty at 15744; realty, pharma top gainers

Pharma Reviews: Mankind Pharma launches drug to treat black fungus

The drug firm always strives to launch affordable medicines with an ... approval from the Drug Controller General of India (DCGI), the drug maker noted
Read more: Mankind Pharma launches drug to treat black fungus

Pharma Reviews: Mankind Pharma launches Posaconazole Gastro resistant tablets to treat black fungus

The drug firm always strives to launch affordable medicines with an ... The drug has received approval from the Drug Controller General of India ...
Read more: Mankind Pharma launches Posaconazole Gastro resistant tablets to treat black fungus

Pharma Reviews: Stock Market Live Updates: Sensex trades higher, Nifty above 15700 led by PSU Bank, metals ...

Stock Market Live Updates: Indian indices are trading higher, tracking gains in Asian peers, with ... Metals, PSU Bank, pharma, IT and realty indices are leading the gains. ... Three IPOs to hit the market next week; check details here.
Read more: Stock Market Live Updates: Sensex trades higher, Nifty above 15700 led by PSU Bank, metals ...

Pharma Reviews: Coronavirus Vaccine: Apart from Covishield, Covaxin, list of vaccines being developed in India

Not only is India a hub of vaccine and medical manufacturing, but a lot of the COVID-19 vaccines being worked on domestically are also based on ...
Read more: Coronavirus Vaccine: Apart from Covishield, Covaxin, list of vaccines being developed in India

Pharma Reviews: Here's how Uber tunes its algos for Indian roads

Majority of the players in Pharma industry are exposed to cyber attacks: Nandakishore Harikumar, CEO & Founder, Technisanct. Healthcare data is a ...
Read more: Here's how Uber tunes its algos for Indian roads

Pharma Reviews: DRDO developed 'affordable' COVID-19 drug priced at Rs 990 per sachet

According to the EoI document, it is proposed to offer transfer of technology (ToT) of 2-DG to Indian pharmaceutical firms for production. DRDO had ...
Read more: DRDO developed 'affordable' COVID-19 drug priced at Rs 990 per sachet

Pharma Reviews: CSIR-IICT licenses process knowhow for synthesis of 2-Deoxy-D-Glucose to Lee Pharma

Indian Institute of Chemical Technology, (IICT), a constituent laboratory of CSIR and Lee Pharma, an integrated pharmaceutical company, based in ...
Read more: CSIR-IICT licenses process knowhow for synthesis of 2-Deoxy-D-Glucose to Lee Pharma

Pharma Reviews: Hiring Trends in Pharma Industry in 2021

by Ahmedali N The Indian Pharma industry presently finds itself unique in creating jobs, developing vaccines, and firmly reiterating its status as the ...
Read more: Hiring Trends in Pharma Industry in 2021

US FDA News: FDA In Brief: FDA Provides Guidance on Measuring Patient-Reported Outcomes in Cancer Clinical Trials

The FDA issued draft guidance to address which patient-reported outcomes concepts to measure in cancer clinical trials.
Read more: FDA In Brief: FDA Provides Guidance on Measuring Patient-Reported Outcomes in Cancer Clinical Trials

Pharma Reviews: Mega contribution of Indian auto industry in the fight against Covid

Our leadership and administration, the medical and health care system, our infrastructure and institutions, the emergency services and pharma ...
Read more: Mega contribution of Indian auto industry in the fight against Covid

Pharma Reviews: See pharma upcycle for next 2-3 years, expect mid to high teens earnings growth: Morgan Stanley

“Pharma sector is now trading at 25-28 times March FY22 PE,” he stated. Baisiwala expects the Indian pharma companies to grow. “US market is a very ...
Read more: See pharma upcycle for next 2-3 years, expect mid to high teens earnings growth: Morgan Stanley

Pharma Reviews: SVKM's NMIMS Opens Admissions for Integrated B. Pharm. + MBA (Pharma. Tech.) Program

The Indian pharmaceutical sector is a rapidly-growing industry with a need for skilled professionals who have the ability to understand and navigate ...
Read more: SVKM's NMIMS Opens Admissions for Integrated B. Pharm. + MBA (Pharma. Tech.) Program

Pharma Reviews: Market LIVE Updates: Indices trade higher with Nifty above 15750; PSU banks in focus

Market LIVE Updates: Indices trade higher with Nifty above 15,750; PSU banks ... Global digital currency exchanges are exploring ways to set up in India, ... higher with Nifty near to 15,800 supported by the pharma and PSU banking ...
Read more: Market LIVE Updates: Indices trade higher with Nifty above 15750; PSU banks in focus

Pharma Reviews: Market LIVE Update: Sensex up 88 pts, Nifty at 15781; realty, pharma gain

Indian markets opened higher on Wednesday. Asian markets slipped lower on cue from Wall Street peers, as the latter saw a mixed close amid lack of ...
Read more: Market LIVE Update: Sensex up 88 pts, Nifty at 15781; realty, pharma gain

Pharma Reviews: USFDA grants approval for Aduhelm as the first and only Alzheimer's drug in almost two decades

Why pharma needs digital engagement now more than ever? The pharmaceutical industry is shifting its focus to integrating technology into product ...
Read more: USFDA grants approval for Aduhelm as the first and only Alzheimer's drug in almost two decades

Pharma Reviews: Serum Institute of India seeks DCGI's nod to manufacture Covid vaccine Sputnik V

Healthcare company owner and pharma lab employee held in inter-state fake Favipiravir racket. The drug has been widely used for Covid-19 treatment ...
Read more: Serum Institute of India seeks DCGI's nod to manufacture Covid vaccine Sputnik V

Pharma Reviews: PLI 2.0 for Pharma Sector – Reinforcing India as the 'Pharmacy of the World'

The Indian government announced a production-linked incentive (“PLI 1.0”) scheme on 21 July 2020 aimed at boosting India's bulk drug security. This ...
Read more: PLI 2.0 for Pharma Sector – Reinforcing India as the 'Pharmacy of the World'

US FDA News: Coronavirus (COVID-19) Update: June 8, 2021

Coronavirus (COVID-19) Update: June 8, 2021
Read more: Coronavirus (COVID-19) Update: June 8, 2021

Pharma Reviews: Ocugen pays USD 15 mn upfront to Bharat Biotech for Covaxin rights in Canada

... upfront to the Indian drug maker for extending the vaccine rights to Canada. ... The Indian biotech company and Ocugen Inc have entered into a definitive ... to co-develop, supply, and commercialise Covaxin for the US market.
Read more: Ocugen pays USD 15 mn upfront to Bharat Biotech for Covaxin rights in Canada

US FDA News: 2021 Biologics Recalls

Listing of the 2021 Biologics Recalls
Read more: 2021 Biologics Recalls

US FDA News: Urgent Voluntary Notification: FiberCel Fiber Viable Bone Matrix (“FiberCel”) - Lot Number: NMDS210011

Aziyo Biologics, Inc., (“Aziyo”) is the manufacturer of record for FiberCel Fiber Viable Bone Matrix (“FiberCel”) and is voluntarily recalling one Lot of the FiberCel product, Donor Lot Number: NMDS210011.
Read more: Urgent Voluntary Notification: FiberCel Fiber Viable Bone Matrix (“FiberCel”) - Lot Number: NMDS210011

Pharma Reviews: View: An inter-connected pharma world

Currently pegged at USD 41 billion, Indian pharmaceuticals market is expected to reach USD 65 billion by 2024 and to USD120 billion by 2030.
Read more: View: An inter-connected pharma world

Pharma Reviews: Contract Pharma-The Neglected Sector

... Manufacturing Organisations (CDMO) sector has rarely captured limelight although being a potential in the Indian pharmaceutical sector. It could be ...
Read more: Contract Pharma-The Neglected Sector

Pharma Reviews: Share Market Highlights: Sensex ends 50 pts lower, Nifty closes at 15740; Tech Mahindra, Bharti ...

Share Market News Today | Sensex, Nifty, Share Prices Highlights: ... Surya India, Suven Pharmaceuticals, Talbros Automotive Components, Titagarh ...
Read more: Share Market Highlights: Sensex ends 50 pts lower, Nifty closes at 15740; Tech Mahindra, Bharti ...

Pharma Reviews: Indian Pharma Market - Covid-19 Induced Demand Pushes Growth To 47.8%: Anand Rathi

On expected lines, the Indian pharma market grew at a robust 47.8% in May. The Covid-19 outbreak had a marked impact on industry volumes last ...
Read more: Indian Pharma Market - Covid-19 Induced Demand Pushes Growth To 47.8%: Anand Rathi

Pharma Reviews: Indian Pharma Market - Covid-19 Boost Sustains In May As Well: Motilal Oswal

Indian pharma market growth was 47.8% YoY in May 2021 versus 51.5% ... On a moving annual total basis, industry growth came in at 10.8% YoY.
Read more: Indian Pharma Market - Covid-19 Boost Sustains In May As Well: Motilal Oswal

Pharma Reviews: Coronavirus News Live Updates: Free COVID-19 vaccines, food to cost India an additional $11 ...

The strong growth momentum for the Indian Pharmaceutical Market (IPM) seen in April continued in May as well. IPM growth was at 47.8% year-on-year ...
Read more: Coronavirus News Live Updates: Free COVID-19 vaccines, food to cost India an additional $11 ...

Pharma Reviews: Drug repurposing to fight against Covid-19

To add to this, there are additional challenges for pharmaceutical firms, ... Amit Chopra is Managing Director, India and South Asia, Thermo Fisher ...
Read more: Drug repurposing to fight against Covid-19

Pharma Reviews: Social Media Conversations - The New Research Tool for Pharma Sector

Rapid digital transformation: A siren call for India's healthcare. The world has witnessed how the healthcare systems of several developed nations broke ...
Read more: Social Media Conversations - The New Research Tool for Pharma Sector

US FDA News: FDA Grants Accelerated Approval for Alzheimer’s Drug

The FDA approved a drug for the treatment of Alzheimer’s under the accelerated approval pathway, which can be used for a drug for a serious or life-threatening illness that provides meaningful therapeutic advantage over existing treatments.
Read more: FDA Grants Accelerated Approval for Alzheimer’s Drug

Pharma Reviews: Nifty closes at record high, Sensex up 228 pts; power, oil and gas top gainers

Benchmark Indian equity indices closed higher on Monday. ... Financial, pharma, metals and realty sectors were in red on the Nifty. Among broader ...
Read more: Nifty closes at record high, Sensex up 228 pts; power, oil and gas top gainers

Pharma Reviews: Covid-19 has unlocked new opportunities for the Indian pharma sector: Sudarshan Jain

With several Indian companies bringing in medicines to build a strong Covid portfolio, how important is the role of collaboration between global and ...
Read more: Covid-19 has unlocked new opportunities for the Indian pharma sector: Sudarshan Jain

Pharma Reviews: This pharma firm in Gurugram first manufactured the drug that treats black fungus in India

Therefore, pharmaceutical companies were manufacturing it only in limited ... India's first Liposomal Amphotericin B was launched on National ...
Read more: This pharma firm in Gurugram first manufactured the drug that treats black fungus in India